Philip James Johnson
Overview
Explore the profile of Philip James Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, et al.
Liver Cancer
. 2022 Aug;
11(4):354-367.
PMID: 35978604
Introduction: Several clinical trials comparing the efficacy and safety of transarterial chemoembolization (TACE) plus molecular-targeted agents versus TACE alone revealed no clinical benefits in progression-free survival (PFS) or overall survival...
2.
Johnson P, Pinato D, Kalyuzhnyy A, Toyoda H
J Clin Oncol
. 2022 Mar;
40(19):2078-2082.
PMID: 35344390
No abstract available.
3.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, et al.
Gut
. 2019 Dec;
69(8):1492-1501.
PMID: 31801872
Objective: This trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint and pre-treatment of sorafenib before initial TACE....